Here below are the publications (12) participated by Alessandro Ceschi using the term string sars-cov (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).
Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
iScience, 20 gennaio 2023

2) Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Science, 20 ottobre 2022

3) ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Science, 12 agosto 2022

4) P1245 Polymorphic Variants of HSD3B1 Gene Confer Different Outcome in Specific Subgroups of Patients Infected With SARS-CoV-2
Frontiers in Medicine, 7 luglio 2022

5) Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients
PLoS One, 10 febbraio 2022

6) The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination
Journal of Thrombosis and Haemostasis, 8 giugno 2021

7) Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2
Science, 18 maggio 2021

8) Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland
The Lancet Regional Health - Europe, febbraio 2021

9) Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Cell, 28 gennaio 2021

10) Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Cell, https://www.cell.com/cell/fulltext/S0092-8674(20)31234-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420312344%3Fshowall%3Dtrue

11) Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients
Endocrine, https://link.springer.com/article/10.1007/s12020-020-02465-4

12) Clinical Characteristics and Management of a Liver Transplanted Patient Admitted With SARS-CoV-2 Infection
Clinics and Research in Hepatology and Gastroenterology, https://www.sciencedirect.com/science/article/pii/S2210740120301595?via%3Dihub
Alessandro Ceschi
is Head of Research Programs [Rif. 20700]
at Istituto di Scienze Farmacologiche della Svizzera Italiana (ISFSI) (Rif. ISFSI)
Viale Officina 3 6500 Bellinzona